肥厚型心肌病患者中阻塞性睡眠呼吸暂停与代谢异常的关联
本研究纳入587例肥厚型心肌病患者,分析阻塞性睡眠呼吸暂停(OSA)与代谢异常的关系。58.6%的患者存在OSA,中重度OSA及呼吸暂停低通气指数对数与肥胖、血压升高和甘油三酯升高独立相关,但与空腹血糖升高及高密度脂蛋白胆固醇降低无独立关联。OSA严重程度与部分代谢异常谱独立相关,尚需临床试验确定治疗OSA能否改善代谢异常及长期结局。
要点
- 肥厚型心肌病患者中OSA患病率达58.6%。
- 中重度OSA与肥胖、血压升高和甘油三酯升高独立相关。
- OSA与空腹血糖升高及高密度脂蛋白胆固醇降低无独立关联。
核心结论
- OSA严重程度与肥厚型心肌病患者部分代谢异常谱独立相关。
研究设计与样本
- 单中心研究纳入587例在阜外医院接受睡眠评估的肥厚型心肌病患者,收集临床特征、多导睡眠图及代谢指标数据。
主要发现
- 344例(58.6%)存在OSA,OSA患者年龄更大、男性更多且临床合并症更多。
- 体重指数、血压、空腹血糖和甘油三酯均随OSA严重程度增加(均P < 0.001),高密度脂蛋白胆固醇降低(P = 0.046)。
- 多因素分析中,中重度OSA与肥胖(OR 2.42;95%CI 1.48-3.95)、血压升高(OR 1.99;95%CI 1.42-3.26)和甘油三酯升高(OR 1.71;95%CI 1.05-2.78)独立相关。
- Log(呼吸暂停低通气指数+1)与肥胖(OR 1.60;95%CI 1.31-1.95)、血压升高(OR 1.31;95%CI 1.08-1.60)和甘油三酯升高(OR 1.24;95%CI 1.02-1.51)独立相关。
- 中重度OSA及Log(AHI+1)与空腹血糖升高(OR 0.88;95%CI 0.50-1.52和OR 1.02;95%CI 0.82-1.28)及高密度脂蛋白胆固醇降低(OR 1.30;95%CI 0.83-2.04和OR 1.06;95%CI 0.89-1.27)无独立关联。
临床怎么用
- 对肥厚型心肌病患者应关注OSA筛查,尤其合并肥胖、血压升高或甘油三酯升高者。
- OSA严重程度可能提示代谢异常风险,但需临床试验验证治疗OSA能否改善代谢及长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Metabolic abnormalities have been associated with long-term cardiac mortality in patients with hypertrophic cardiomyopathy (HCM). Obstructive sleep apnea (OSA) is a risk factor for metabolic abnormalities in general populations, but association between OSA and metabolic abnormalities in HCM is still undefined. This study aimed to investigate the relationship between OSA and metabolic dysfunction in a large series of patients with HCM. METHODS: A total of 587 patients with HCM who underwent sleep evaluations at Fuwai Hospital were included. Data from clinical characteristics, polysomnography studies, and metabolic measurements were collected. RESULTS: OSA was present in 344 patients (58.6%). Patients with OSA were older, more often male, and had more clinical comorbidities. Body mass index, blood pressure, fasting glucose, and triglycerides all increased (all P < 0.001) and high-density lipoprotein cholesterol decreased (P = 0.046) with the severity of OSA. In multivariate analysis, moderate to severe OSA and Log (apnea-hypopnea index + 1) were independently associated with obesity (odds ratio [OR], 2.42; 95% CI, 1.48-3.95 and OR, 1.60; 95% CI, 1.31-1.95), elevated blood pressure (OR, 1.99; 95% CI, 1.42-3.26 and OR, 1.31; 95% CI, 1.08-1.60), and elevated triglycerides (OR, 1.71; 95% CI, 1.05-2.78 and OR, 1.24; 95% CI, 1.02-1.51 but not elevated fasting glucose (OR, 0.88; 95% CI, 0.50-1.52 and OR, 1.02; 95% CI, 0.82-1.28) or reduced high-density lipoprotein cholesterol (OR, 1.30; 95% CI, 0.83-2.04 and OR, 1.06; 95% CI, 0.89-1.27). CONCLUSIONS: Severity of OSA is independently associated with some profiles of metabolic abnormalities. Clinical trials are required to determine whether OSA treatment improves metabolic abnormalities and long-term outcomes in patients with HCM.
引用
- Wang J, Xu H, Yuan J, et al. Association Between Obstructive Sleep Apnea and Metabolic Abnormalities in Patients With Hypertrophic Cardiomyopathy. J Clin Endocrinol Metab. 2021. PMID: 33420791. doi:10.1210/clinem/dgab015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。